PET-CT Scanner Device Market – Insights
A positron emission tomography (PET) - computed tomography (CT) scan reveals information about both the structure and function of cells and tissues in the body during a single imaging session. In recent times, majority of PET scans are performed on instruments that are combined with PET and CT scanners. The combined PET-CT scans provide images that identify the anatomic location of abnormal metabolic activity within the body. The combined scans have been shown to provide more accurate diagnoses than the two scans performed separately.
The diagnosis of various diseases such as cancer, heart diseases, and certain brain disorders require the use of both PET and CT scans. PET scanners measure metabolic activity, whereas CT scanners highlight anatomical features. The risk to poor superimposition of separate imaging is reduced and the hybrid PET-CT process lessens burden on the patient by simplifying the scanning process. The use of PET-CT scanner hybrids combine the strengths of two well-established imaging modalities and helps in accurate diagnosis, localizing, and monitoring of the disease. Moreover, PET-CT scanners can record the images in extremely short time (less than a minute).
The global PET-CT scanner device market size was valued at US$ 1.9 billion in 2017 and is expected to witness a CAGR of 5.1% over the forecast period (2018 – 2026).
Global PET-CT Scanner Device Market Share (%) Analysis, By Application, 2017
Source: Coherent Market Insights Analysis (2018)
Increasing prevalence of chronic diseases and rising geriatric population is expected to drive the PET-CT scanner device market revenue
Rising prevalence of infectious and chronic diseases such as cancer and heart disease across the globe and increasing demand for effective diagnostic systems is expected to drive the PET-CT scanner market size. According to the National Centre for Health Statistics, 2011, heart disease is the leading cause of death in the U.S., killing over 600,000 people each year.
According to the International Agency for Research on Cancer (IARC), in 2012, an estimated 14.1 million new cancer cases were reported, globally. Among these, the most common form of cancer was lung cancer (13%), breast cancer (11.9%), and colorectal cancer (9.7%). According to the Centers for Disease Control and Prevention (CDC), February 2018 data, around 22,000 men and 9,000 women suffer from liver cancer, and around 16,000 men and 8,000 women die due to liver cancer, every year in the U.S.
Moreover, rising cases of brain illness such as Alzheimer’s and traumatic brain injury is also contributing to market growth. For instance, according to the Alzheimer’s Association, in 2017, over 5 million people were estimated to be suffering from Alzheimer’s disease, which was also reported to be the sixth-leading cause of death in the U.S.
PET-CT Scanner Device Market - Restraints
PET-CT scan test results of diabetic patients or patients who consumed any food few hours prior to the examination could be adversely affected, owing to altered blood sugar or blood insulin levels. A person who is very obese may not fit into the opening of a conventional PET-CT unit. Motion artifacts could also be a major problem with PET-CT imaging when compared to the standard PET. Moreover, this scan is not recommended for all patients including pregnant women due to harmful radiation causing side effects to the body. All these factors can negatively impact the PET-CT scanner device market growth.
PET-CT Scanner Device Market - Regional Insights
On the basis of region, the global PET-CT scanner device market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the global PET-CT scanner device market, owing to rising number of traumatic brain injury cases in the U.S. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2013, around 282,000 people were diagnosed with brain injury and around 50,000 people died due to traumatic brain injury in the U.S. It is estimated to be a major cause of disability and death in the U.S.
Europe is also expected to show significant growth in the PET-CT scanner device market, owing to huge number of installed devices and presence of major industry players such as Koninklijke Philips N.V., Siemens AG, and others in the region contributing major revenue share to the market. According to the European Association of Nuclear Medicine (EANM) Annual Congress held in France, in 2012, there were 577 providers of PET and/or PET/CT in Western Europe, and PET/CT accounted for 92% of the installed systems.
Moreover, the installed base of PET-CT continues to shift from larger institutions into settings such as general hospitals and private practice. Increasing government funding is also a major factor for the technology adoption. For instance, in England, as of August 2015, PET-CT is funded centrally by the National Health Service (NHS) England.
Global PET-CT Scanner Device Market Value (US$ Mn) & Y-o-Y Growth (%)
Source: Coherent Market Insights Analysis (2018)
PET-CT Scanner Device Market - Competitive Landscape
Key players operating in the global PET-CT scanner device market include General Electric Co., Hitachi, Ltd., Mediso Ltd., Koninklijke Philips N.V., PerkinElmer, Inc., Positron Corporation, Siemens AG, Shimadzu Corporation, Toshiba Corporation, and Yangzhou Kindsway Biotech Co. Ltd. Manufacturers are continually bringing in new PET/CT design. New technology enables more precise measurements of metabolic processes and data quantification, including assessment of cancerous tissue, neurologic disease, and cardiac blood flow (perfusion).
Positron Emission Tomography (PET) and Computer Tomography (CT) scanners are combined to provide utmost diagnostic capabilities to patients. This combination produces a highly sensitive imaging and detects diseases at an early stage that are often undetected by CT alone or by other imaging procedures such as magnetic resonance imaging (MRI). The CT component of the system adds anatomical information to the PET scan and provides accurate information on the location of disease in the body. These equipment are used for diagnosis of different types of cancers, such as colorectal cancers and lymphomas, as well as some neurological and cardiac conditions.
Increasing prevalence of various chronic diseases such as different types of cancer, heart conditions, and neurological disorders demand disease diagnosis at early stage. For instance, in 2018, 1,735,350 new cancer cases and 609,640 cancer deaths are projected to occur in the U.S. It is a powerful tool for determining and diagnosing the stage of many cancer types, including breast, brain, cervical, colorectal, esophageal, head and neck, lung, lymphoma, melanoma, pancreatic, and thyroid cancers. PET/CT is also finding potential value for radiation therapy planning. With recent advances in intensity-modulated radiation therapy, it is possible to treat tumors while reducing radiation doses to non-targeted organs when compared with traditional techniques.
PET-CT scans can also detect early onset of neurological disorders such as Alzheimer’s disease. It is frequently used to identify areas of the brain causing epileptic seizures. However, PET-CT scan is not recommended for all patients due to harmful radiation that causes side effects to the body. For instance, it is not suitable for pregnant women, as the radiation could harm the baby.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.